<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>肿瘤资讯 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-11T23:07:34+08:00</updated>
  <subtitle>分享肿瘤领域最新进展，传播正确肿瘤防治理念，提高全社会对肿瘤的关注！新浪微博：@肿瘤资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【2673】2020 SABCS乳腺癌前沿进展大赏</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/kSIaRhq6UzU_EJk2u10u2g</id>
    <link href="https://mp.weixin.qq.com/s/kSIaRhq6UzU_EJk2u10u2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>帕博利珠单抗获批头颈鳞癌一线治疗适应症，郭晔教授开出首张处方</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/tvoIsFQc7pExNOEIletifw</id>
    <link href="https://mp.weixin.qq.com/s/tvoIsFQc7pExNOEIletifw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>ORIENT-32研究者邵国良教授：信迪利单抗联合贝伐珠单抗为晚期肝癌带来新希望，联合局部治疗有望成为治疗新模式</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/hUi4ZfMcH5DeCBoOMRgzng</id>
    <link href="https://mp.weixin.qq.com/s/hUi4ZfMcH5DeCBoOMRgzng" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>透过现象看本质，樊旼教授谈 PD-L1 抑制剂全新抗肿瘤机制和 SCLC 免疫治疗</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/Puyp2hJb0ljOKKSCF50WJg</id>
    <link href="https://mp.weixin.qq.com/s/Puyp2hJb0ljOKKSCF50WJg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 | 孙小峰教授：瑞派替尼已在海南博鳌获优先使用，新药新政策为GIST患者雪中送炭</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/zuNryDgcnN_rY8VXLO7W0A</id>
    <link href="https://mp.weixin.qq.com/s/zuNryDgcnN_rY8VXLO7W0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>别问！ 问就是送福利（文末有彩蛋）</title>
    <updated>2020-12-11T19:40:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/KlbOLpiEvfB4hWNs8wC0xw</id>
    <link href="https://mp.weixin.qq.com/s/KlbOLpiEvfB4hWNs8wC0xw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2672】【第五期】奇遇说丨“T+A”在早中期肝细胞癌治疗的探索</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/Oer4_EBuku5kIpWe0HpbqQ</id>
    <link href="https://mp.weixin.qq.com/s/Oer4_EBuku5kIpWe0HpbqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【说文解泌】一个临床病例带来的思考：免疫时代下肌层浸润性膀胱癌保膀胱治疗</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/HpG44kVOQj2m_tWiHILebw</id>
    <link href="https://mp.weixin.qq.com/s/HpG44kVOQj2m_tWiHILebw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】张剑教授：DB01研究结果更新，DS-8201这匹黑马在HER2+晚期乳腺癌治疗中一骑绝尘</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/iNqeNBXvAiJsXVAvS1zzKA</id>
    <link href="https://mp.weixin.qq.com/s/iNqeNBXvAiJsXVAvS1zzKA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 SABCS】“中国之声”闪耀SABCS舞台，精彩不容错过</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/YnVmQiY_C8teCZHrMFdlcg</id>
    <link href="https://mp.weixin.qq.com/s/YnVmQiY_C8teCZHrMFdlcg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>精准治疗新时代，如何处理结直肠癌肝转移这个“老话题”</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/bFzHAbPsvbrrzcYZC_j2YA</id>
    <link href="https://mp.weixin.qq.com/s/bFzHAbPsvbrrzcYZC_j2YA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【会议预告】第四届长征疑难肿瘤论坛暨中国医药教育协会疑难肿瘤专业委员会年会</title>
    <updated>2020-12-10T19:15:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-10:/s/1QUmhk8YWy5hNUtnuT5AzA</id>
    <link href="https://mp.weixin.qq.com/s/1QUmhk8YWy5hNUtnuT5AzA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2671】ESMO-Asia 2020：基于分子分型的子宫内膜癌放射治疗的选择</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/Bba-Phil9Q0n-TmuM7puLw</id>
    <link href="https://mp.weixin.qq.com/s/Bba-Phil9Q0n-TmuM7puLw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【中肿前列腺癌单病种团队】多方整合 改善患者生存质量</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/MJRXsMJ9hi754dU2llxf6A</id>
    <link href="https://mp.weixin.qq.com/s/MJRXsMJ9hi754dU2llxf6A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【2020 ASH对话大咖】江倩教授：国产第三代BCR-ABL抑制剂再领风潮，HQP1351治疗CML研究荣耀亮相ASH</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/rAyN2V0XmRXj7vVFkTYN8w</id>
    <link href="https://mp.weixin.qq.com/s/rAyN2V0XmRXj7vVFkTYN8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李峻岭教授：精准、高效、脑保护，RET融合阳性NSCLC迎来曙光！</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/NuqvWJRhKun7xs6KIlj3_Q</id>
    <link href="https://mp.weixin.qq.com/s/NuqvWJRhKun7xs6KIlj3_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“GIST 新时空”专栏 | 齐长松教授公开课：晚期耐药GIST的高度异质性及治疗策略</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/ESwBe1WzWRnaefyXC0JvqQ</id>
    <link href="https://mp.weixin.qq.com/s/ESwBe1WzWRnaefyXC0JvqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【CDK4/6i学院】从两例乳腺癌骨转移患者看内分泌敏感性对CDK4/6抑制剂联合内分泌治疗的影响</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/EQG_FcsfCt6V1jhHQ73AjQ</id>
    <link href="https://mp.weixin.qq.com/s/EQG_FcsfCt6V1jhHQ73AjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 CSCO扬（YOUNG）帆远航冠军之战震撼登场 | 新赛制、新高度、新起点</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/enPdfyGcSTTbRlYtsGM7iA</id>
    <link href="https://mp.weixin.qq.com/s/enPdfyGcSTTbRlYtsGM7iA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020广州骨与软组织肉瘤高峰论坛</title>
    <updated>2020-12-09T19:42:00+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/d-yYZAuW2jb0cQwc-ZAdhw</id>
    <link href="https://mp.weixin.qq.com/s/d-yYZAuW2jb0cQwc-ZAdhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>